Global Multiple Myeloma Disease Coverage Forecast and Market Analysis Report 2021: Comprehensive Collection of All Recent Events that has Affected the Market and Future Trends
12 avr. 2021 06h58 HE
|
Research and Markets
Dublin, April 12, 2021 (GLOBE NEWSWIRE) -- The "Multiple Myeloma Disease Coverage Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering. Multiple myeloma is...
Rhizen Pharmaceuticals S.A. to present preclinical data of RP6530 (dual PI3K delta/gamma inhibitor) in Multiple Myeloma
18 nov. 2014 07h00 HE
|
Rhizen Pharmaceuticals SA
La Chaux-de-Fonds, Switzerland, Nov. 18, 2014 (GLOBE NEWSWIRE) -- Rhizen Pharmaceuticals S.A. announces a poster presentation for
RP6530, a novel dual PI3K delta/gamma inhibitor in Multiple
Myeloma.
...